INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy
Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.
-
GLP Compliance In A Modern Lab: What Compliant Actually Requires In 2025
GLP compliance isn’t binary. Real defensibility depends on rigorous QA, validated electronic systems, and operational maturity — not just a label.
-
Navigating The New Landscape Of Oncology Clinical Trials: A Strategic Imperative For Operations Teams
The oncology landscape is growing but faces high screen-fail rates and trial complexity. To succeed, teams must move past traditional playbooks and adopt centralized pre-screening pipelines.
-
5 Myths About Patient Payments In Clinical Trials
Digital payment solutions debunk myths around clinical trial compensation, improving participant retention, easing site burden, and enabling smoother global operations through faster, more reliable payments.
-
Reduce Patient And Site Burden Through Excellence In Trial Logistics1/14/2025
Watch for an insightful webinar where you’ll explore the latest strategies and innovations for managing clinical trial operations with a focus on device provisioning and data workflows.
-
Demystifying Cell And Gene Therapy Studies In Australia And The Broader APAC Region11/17/2024
Though conducting your clinical trial in Australia may initially seem daunting, the benefits are ample. Australia is home to qualified CRO partners that will guide your CGT to regulatory success.
-
Launching A Unified Global Sales Team In 90 Days11/7/2025
A global CRO united 300+ sales and executive leaders across five continents for a dynamic, space-themed meeting that strengthened culture, deepened product understanding, and inspired alignment toward annual growth goals.
-
Why Should Site Agility Be Your Next Competitive Advantage?1/26/2026
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.
-
Quotient Sciences Capacity Update July 20257/29/2025
Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Review PCI's commitment to environmental and social responsibility, including its ambitious sustainability goals and achievements across various categories.
-
With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
-
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
With 80% of trials failing to enroll patients on time, improved collaboration between sites and sponsors is essential.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.